Russell Skibsted
Net worth: 294 450 $ as of 31/03/2024
Profile
Russell L.
Skibsted served as Director-Corporate Development at Pinkerton, Inc. He was also Chief Financial Officer & Managing Director at RSL Venture Partners LP, Chief Financial & Accounting Officer at Lineage Cell Therapeutics, Inc., Chief Business Officer & Senior Vice President at Spectrum Pharmaceuticals, Inc., and Chief Financial & Business Officer, Executive VP at Rockwell Medical, Inc. Skibsted also held positions as Vice President at GE Capital Services, Chief Financial Officer, Secretary, CAO & SVP at Aeolus Pharmaceuticals, Inc., Chief Financial Officer at Talon Therapeutics, Inc., and Chief Financial Officer & Partner at Asset Management Co. He was also Chief Financial & Accounting Officer at OncoCyte Corp., Chief Financial Officer at Proove Biosciences, Inc., and Chief Financial Officer at AgeX Therapeutics, Inc. Skibsted received his undergraduate degree from Claremont McKenna College and his MBA from Stanford Graduate School of Business.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
ALIMERA SCIENCES, INC.
0.14% | 21/11/2023 | 75,500 ( 0.14% ) | 294 450 $ | 31/03/2024 |
Former positions of Russell Skibsted
| Companies | Position | End |
|---|---|---|
| ALIMERA SCIENCES, INC. | Director of Finance/CFO | 02/01/2024 |
| AGEX THERAPEUTICS, INC. | Director of Finance/CFO | 15/05/2020 |
| LINEAGE CELL THERAPEUTICS, INC. | Director of Finance/CFO | 07/01/2019 |
| ASTERIAS BIOTHERAPEUTICS INC | Director of Finance/CFO | 17/11/2016 |
Proove Biosciences, Inc.
 Proove Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Proove Biosciences, Inc. provides genetic testing services. It engages in the research, investigation and development of patent-protected precision medicine profiles that combine genetic and clinical data into reports to help clinicians individualize medicine selection and dosing for chronic pain. The company was founded by Brian Meshkin in 2009 and is headquartered in Irvine, CA. | Director of Finance/CFO | 01/11/2015 |
Training of Russell Skibsted
| Claremont McKenna College | Undergraduate Degree |
| Stanford Graduate School of Business | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 7 |
|---|---|
| LINEAGE CELL THERAPEUTICS, INC. | Health Technology |
| SPECTRUM PHARMACEUTICALS, INC. | Health Technology |
| ROCKWELL MEDICAL, INC. | Health Technology |
| ALIMERA SCIENCES, INC. | Health Technology |
| PHARMAGEN, INC. | Distribution Services |
| AEOLUS PHARMACEUTICALS, INC. | Health Technology |
| ONCOCYTE CORPORATION | Health Technology |
| Private companies | 8 |
|---|---|
Asterias Biotherapeutics, Inc.
 Asterias Biotherapeutics, Inc. BiotechnologyHealth Technology Asterias Biotherapeutics, Inc. is a clinical-stage biotechnology company, which focuses on developing and commercializing novel therapies in the emerging fields of cell therapy and regenerative medicine. Its product candidates include AST-OPC1, trial for spinal cord injuries; AST-VAC1, a patient specific cancer immunotherapy focused on acute myeloid leukemia; and AST-VAC2, a non-patient-specific cancer immunotherapy for non-small cell lung cancer. The company was founded on September 24, 2012 and is headquartered in Fremont, CA. | Health Technology |
GE Capital Services
 GE Capital Services Aerospace & DefenseElectronic Technology Part of GE Aerospace, GE Capital Services is a diversified manufacturer of high-tech products. The private company is based in Fairfield, CT. | Electronic Technology |
Talon Therapeutics, Inc.
 Talon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Talon Therapeutics, Inc. is a biopharmaceutical company, which is engaged in the developing and commercializing new and differentiated cancer therapies. The firm is developing the Marqibo for the treatment of acute lymphoblastic leukemia and other blood cancers including lymphoma. Its Menadione topical lotion is a compound which is developed for the prevention and treatment of skin toxicity associated with epidermal growth factor receptor inhibitors. The company was founded by Mark J. Ahn in 2002 and is headquartered in San Mateo, CA. | Health Technology |
Asset Management Co.
 Asset Management Co. Investment ManagersFinance Asset Management Co. is a venture capital firm. The company was founded in 1965 and is headquartered in East Palo Alto, CA. | Finance |
| Pinkerton, Inc. | |
RSL Venture Partners LP
 RSL Venture Partners LP Financial ConglomeratesFinance RSL Venture Partners provides investment services. The company is headquartered in United States. | Finance |
Proove Biosciences, Inc.
Proove Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Proove Biosciences, Inc. provides genetic testing services. It engages in the research, investigation and development of patent-protected precision medicine profiles that combine genetic and clinical data into reports to help clinicians individualize medicine selection and dosing for chronic pain. The company was founded by Brian Meshkin in 2009 and is headquartered in Irvine, CA. | Commercial Services |
AgeX Therapeutics, Inc.
 AgeX Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology AgeX Therapeutics, Inc. operates as a biotechnology company, which engages in the development and commercialization of novel therapeutics targeting human aging and degenerative diseases. Its product pipeline includes AGEX-VASC1, AGEX-BAT1, and AGEX-iTR1547. The company was founded by Michael D. West in 2017 and is headquartered in Alameda, CA. | Health Technology |
- Stock Market
- Insiders
- Russell Skibsted